- Home
- SXTC vs NXRT Comparison
SXTC vs NXRT Comparison
Compare SXTC & NXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTC
- NXRT
- Stock Information
- Founded
- SXTC 2005
- NXRT 2014
- Country
- SXTC China
- NXRT United States
- Employees
- SXTC N/A
- NXRT N/A
- Industry
- SXTC Biotechnology: Pharmaceutical Preparations
- NXRT Real Estate Investment Trusts
- Sector
- SXTC Health Care
- NXRT Real Estate
- Exchange
- SXTC Nasdaq
- NXRT Nasdaq
- Market Cap
- SXTC 2.5M
- NXRT N/A
- IPO Year
- SXTC 2019
- NXRT N/A
- Fundamental
- Price
- SXTC $0.57
- NXRT $42.54
- Analyst Decision
- SXTC
- NXRT Hold
- Analyst Count
- SXTC 0
- NXRT 5
- Target Price
- SXTC N/A
- NXRT $48.75
- AVG Volume (30 Days)
- SXTC 696.2K
- NXRT 148.1K
- Earning Date
- SXTC 01-01-0001
- NXRT 10-29-2024
- Dividend Yield
- SXTC N/A
- NXRT 4.45%
- EPS Growth
- SXTC N/A
- NXRT N/A
- EPS
- SXTC N/A
- NXRT 3.35
- Revenue
- SXTC $1,928,497.00
- NXRT $270,841,000.00
- Revenue This Year
- SXTC N/A
- NXRT N/A
- Revenue Next Year
- SXTC N/A
- NXRT $0.89
- P/E Ratio
- SXTC N/A
- NXRT $12.58
- Revenue Growth
- SXTC N/A
- NXRT N/A
- 52 Week Low
- SXTC $0.53
- NXRT $26.21
- 52 Week High
- SXTC $6.39
- NXRT $48.37
- Technical
- Relative Strength Index (RSI)
- SXTC 39.07
- NXRT 33.08
- Support Level
- SXTC $0.67
- NXRT $43.11
- Resistance Level
- SXTC $0.75
- NXRT $42.87
- Average True Range (ATR)
- SXTC 0.09
- NXRT 0.95
- MACD
- SXTC -0.00
- NXRT -0.30
- Stochastic Oscillator
- SXTC 8.96
- NXRT 11.25
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.